LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
191,326,157
Share change
+45,718,730
Total reported value
$438,152,499
Put/Call ratio
1002%
Price per share
$2.29
Number of holders
121
Value change
+$104,558,326
Number of buys
79
Number of sells
28

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2023

As of 30 Jun 2023 LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) had 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 191,326,157 shares of stock of the company.
Largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, and Octagon Capital Advisors LP.
This table shows 121 institutional shareholders of the security as of 30 Jun 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.